Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV

NCT02124044 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

HIV-HCV

Interventions

DRUG: Asunaprevir and Daclatasvir
DRUG: Asunaprevir and Daclatasvir with BMS-791325

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]
[object Object]